Over the course of 2024, we’ve seen all kinds of stories across surgical robotics, ranging from new systems to FDA clearances and more.
Intuitive earns updated FDA labeling on da Vinci X, Xi for radical prostatectomy
The labeling for Intuitive Surgical’s da Vinci states that survival rates for robot-assisted surgeries are comparable to non-automated procedures.
Intuitive’s Tony Jarc discusses the next leap in surgical robotics with AI integration
In this episode of IntuitiveTalks, Tony Jarc, Sr. Director of Digital & Machine Learning at Intuitive, walks us through the evolving landscape of surgical robotics.
2 technologies that will be huge for robotic surgery
Intuitive president Dave Rosa identified two technologies that are going to advance surgical robotics.
Intuitive to discuss future of surgical robots at RoboBusiness
Surgical robotics pioneer Intuitive is outpacing competitors in the industry by doubling down on its multi-port Da Vinci Robot.
Titan Medical licenses out most of its IP to Intuitive, CEO steps down
Titan Medical recently announced it entered into a licensing agreement with Intuitive Surgical and that the company’s CEO is resigning.
Intuitive expects da Vinci procedures to increase at least 12% in 2023
Intuitive Surgical released preliminary Q4 results that included a revenue miss, but the company expects da Vinci surgical robot procedures to grow.
Surgical robotics maker Intuitive misses mark in Q2
Intuitive warned COVID-19 will likely continue to have an adverse impact on da Vinci procedure volumes.
Intuitive to keynote Healthcare Robotics Engineering Forum
Rich Mahoney, Vice President of Research at Intuitive, will discuss the opportunity for healthcare robotics solutions to expand access to quality healthcare at the event.